Buy This Stock Before Everyone Else Does
It can be stressful to watch shares of companies you own (or are thinking about buying) significantly underperform the market. But this also provides an opportunity to scoop up said company's stock on the dip -- if, of course, there are good reasons to think a rebound is in the cards. Take Axsome Therapeutics (NASDAQ: AXSM), a biotech whose shares have been struggling of late.
The drugmaker's stock is down by 21.98% in the past 12 months, compared to gains of 37.54% for the S&P 500. But this clinical-stage biotech has a lot going its way, and with a major potential catalyst in the near future, now might be an excellent time to purchase its shares. Let's look deeper into why Axsome Therapeutics could be a steal at current levels.
Source Fool.com